Chemoinformaics analysis of 2,6-Diisopropylnaphthalene
Molecular Weight | 212.336 | nRot | 2 |
Heavy Atom Molecular Weight | 192.176 | nRig | 11 |
Exact Molecular Weight | 212.156 | nRing | 2 |
Solubility: LogS | -6.5 | nHRing | 0 |
Solubility: LogP | 5.682 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 2 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 0 | No. of Arom Bond | 11 |
nHA | 0 | APOL | 40.0559 |
nHD | 0 | BPOL | 20.0641 |
QED | 0.65 |
Synth | 1.73 |
Natural Product Likeliness | -0.135 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.415 |
Pgp-sub | 0.028 |
HIA | 0.006 |
CACO-2 | -4.608 |
MDCK | 0.0000109 |
BBB | 0.344 |
PPB | 0.980651 |
VDSS | 1.752 |
FU | 0.0237329 |
CYP1A2-inh | 0.861 |
CYP1A2-sub | 0.877 |
CYP2c19-inh | 0.552 |
CYP2c19-sub | 0.497 |
CYP2c9-inh | 0.411 |
CYP2c9-sub | 0.726 |
CYP2d6-inh | 0.841 |
CYP2d6-sub | 0.562 |
CYP3a4-inh | 0.328 |
CYP3a4-sub | 0.54 |
CL | 4.386 |
T12 | 0.08 |
hERG | 0.033 |
Ames | 0.066 |
ROA | 0.242 |
SkinSen | 0.231 |
Carcinogencity | 0.306 |
EI | 0.987 |
Respiratory | 0.017 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.640138 |